ArticleCureus2026
Diagnostic Role of Shear Wave Elastography for Differentiating Benign and Malignant Breast Lesions With Histopathological Examination (HPE) Correlation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a leading cause of mortality worldwide, with invasive ductal carcinoma being the most common malignant tumor. Ultrasonography (USG) is the initial imaging modality for breast lesions, but its low specificity often necessitates invasive histopathological examination (HPE). Shear wave elastography (SWE) is a novel technique that assesses tissue stiffness non-invasively, providing promising results in differentiating benign and malignant breast lesions. This study evaluates the diagnostic accuracy of SWE combined with B-mode USG in characterizing breast lesions and correlates findings with HPE results. A hospital-based prospective observational study was conducted on 50 female patients aged 18 years and above with breast lesions categorized as Breast Imaging-Reporting and Data System (BI-RADS) 3 or higher. SWE demonstrated a sensitivity of 72.72%, a specificity of 85.71%, and a diagnostic accuracy of 80%, highlighting its potential to reduce unnecessary biopsies. This study concludes that SWE is a valuable adjunct to conventional USG for breast lesion evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.